SHOULDER INNOVATIONS, INC. Cost of Revenue
SHOULDER INNOVATIONS, INC. (SI) reported Cost of Revenue of $3.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $3.73M, a 42.52% increase year-over-year.
- SHOULDER INNOVATIONS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $3.72M, a 58.99% increase year-over-year.
- SHOULDER INNOVATIONS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $3.36M, a 71.64% increase year-over-year.
- SHOULDER INNOVATIONS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $2.79M, a 59.44% increase year-over-year.
- SHOULDER INNOVATIONS, INC. cost of goods and services sold for fiscal 2025 was $11.12M, a 52.64% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. cost of goods and services sold for fiscal 2024 was $7.28M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.73M 10-Q · filed 2026-08-06 | $7.46M 10-Q · filed 2026-08-06 | $10.81M derived: sum of 3 quarters · filed 2026-08-06 | $13.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.72M 10-Q · filed 2026-05-13 | $7.08M derived: sum of 2 quarters · filed 2026-05-13 | $9.88M derived: sum of 3 quarters · filed 2026-05-13 | $12.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $6.15M derived: sum of 2 quarters · filed 2026-03-10 | $8.77M derived: sum of 3 quarters · filed 2026-08-06 | $11.12M 10-K · filed 2026-03-10 |
| 2025-09-30 | $2.79M 10-Q · filed 2025-11-12 | $5.42M derived: sum of 2 quarters · filed 2026-08-06 | $7.76M 10-Q · filed 2025-11-12 | $9.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.62M 10-Q · filed 2026-08-06 | $4.96M 10-Q · filed 2026-08-06 | $6.92M derived: sum of 3 quarters · filed 2026-08-06 | $8.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.34M 10-Q · filed 2026-05-13 | $4.30M derived: sum of 2 quarters · filed 2026-05-13 | $6.05M derived: sum of 3 quarters · filed 2026-05-13 | $7.96M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $3.71M derived: sum of 2 quarters · filed 2026-03-10 | $5.62M derived: sum of 3 quarters · filed 2026-03-10 | $7.28M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.75M 10-Q · filed 2025-11-12 | $3.66M derived: sum of 2 quarters · filed 2025-11-12 | $5.33M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.91M 10-Q · filed 2025-09-09 | $3.57M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |